Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Multifiling Mitra Indonesia Tbk. (MFMI) Price & Performance

UBC Medical Indonesia Tbk.Trade
Multifiling Mitra Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Multifiling Mitra Indonesia Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume), while Multifiling Mitra Indonesia Tbk. trades at Rp1,300 (market cap 984.86B). The key difference: Multifiling Mitra Indonesia Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.

LABSMFMI
Market Cap
691.25B984.86B
Volume
635.5K
Lot
6.36K
Turnover
110.15M
Average Price
173.33
Value
110.15M
Indicative Equilibrium Price
174
Indicative Equilibrium Volume
50

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
MFMI
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Multifiling Mitra Indonesia Tbk.

PT Multifiling Mitra Indonesia Tbk (the Company) was established based on the Notarial Deed No. 157 of Misahardi Wilamarta, SH., dated July 9, 1992. MMI is a joint venture company between PT.Multipolar Corp. Tbk. and PT. Lippo Karawaci Tbk, currently serving its customers in 4-big city, Jakarta, Surabaya, Medan dan Bandung.

Read more on MFMI